PT2692355T - Apolactoferrina para o tratamento de doenças por acumulação de ferro - Google Patents

Apolactoferrina para o tratamento de doenças por acumulação de ferro

Info

Publication number
PT2692355T
PT2692355T PT130037781T PT13003778T PT2692355T PT 2692355 T PT2692355 T PT 2692355T PT 130037781 T PT130037781 T PT 130037781T PT 13003778 T PT13003778 T PT 13003778T PT 2692355 T PT2692355 T PT 2692355T
Authority
PT
Portugal
Prior art keywords
apolactoferrin
treatment
iron accumulation
accumulation diseases
diseases
Prior art date
Application number
PT130037781T
Other languages
English (en)
Original Assignee
Tdc Tech Dedicated To Care S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tdc Tech Dedicated To Care S R L filed Critical Tdc Tech Dedicated To Care S R L
Publication of PT2692355T publication Critical patent/PT2692355T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40Transferrins, e.g. lactoferrins, ovotransferrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
PT130037781T 2012-08-01 2013-07-30 Apolactoferrina para o tratamento de doenças por acumulação de ferro PT2692355T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001356A ITMI20121356A1 (it) 2012-08-01 2012-08-01 Apolattoferrina per il trattamento di patologie da accumulo di ferro

Publications (1)

Publication Number Publication Date
PT2692355T true PT2692355T (pt) 2021-09-15

Family

ID=46982698

Family Applications (1)

Application Number Title Priority Date Filing Date
PT130037781T PT2692355T (pt) 2012-08-01 2013-07-30 Apolactoferrina para o tratamento de doenças por acumulação de ferro

Country Status (5)

Country Link
EP (1) EP2692355B1 (pt)
ES (1) ES2886564T3 (pt)
IT (1) ITMI20121356A1 (pt)
PL (1) PL2692355T3 (pt)
PT (1) PT2692355T (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021209652A1 (es) 2020-04-16 2021-10-21 Dermopartners,S.L. Nueva composición para ser usada en el tratamiento y la prevención de infecciones por covid-19 y otros coronavirus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2609954A1 (en) * 2005-06-29 2007-01-04 Nrl Pharma, Inc. Agent for ameliorating heavy metal-induced disorders, and medicinal composition, food and cosmetic containing the same
JP4912057B2 (ja) 2006-06-23 2012-04-04 トヨタ自動車株式会社 車両警報装置
JPWO2008032847A1 (ja) 2006-09-11 2010-01-28 株式会社アップウェル 皮膚外用剤
JP5017531B2 (ja) 2006-09-11 2012-09-05 株式会社アップウェル 口内清浄剤
JP5712429B2 (ja) 2008-07-09 2015-05-07 株式会社アップウェル アポラクトフェリン含有組成物
IT1394514B1 (it) * 2008-07-15 2012-07-05 Biagio Biancardi Nuova composizione per il trattamento di pigmentazione ecchimotiche
JP2010229118A (ja) 2009-03-30 2010-10-14 Up Well:Kk リパーゼ阻害剤
JP5679276B2 (ja) 2009-09-30 2015-03-04 株式会社アップウェル 抗アレルギー剤

Also Published As

Publication number Publication date
EP2692355A1 (en) 2014-02-05
PL2692355T3 (pl) 2021-12-13
ITMI20121356A1 (it) 2014-02-02
ES2886564T3 (es) 2021-12-20
EP2692355B1 (en) 2021-06-16

Similar Documents

Publication Publication Date Title
IL237275A0 (en) Compounds for the treatment of paramoxovirus viral infections
IL263661A (en) Combination therapy for the treatment of glioblastoma
IL239368A0 (en) Sparing–ppar thiazolidinediones and combinations for the treatment of neurodegenerative diseases of the nervous system
EP2906208A4 (en) THERAPEUTIC TREATMENT
HK1213544A1 (zh) 新型二環苯基-吡啶/吡嗪用於治療癌症
EP2906583A4 (en) PEPTIDES FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
EP2906580A4 (en) TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
EP2807111A4 (en) MULTIFUNCTIONAL NANOMATERIALS FOR THE TREATMENT OF CARCINOMES
IL236450A (en) Process for making 5-fluoro-h1-pyrazoles
HK1219224A1 (zh) 角結膜病症的治療劑
ZA201305970B (en) Arylosulfonami for the treatment of cns diseases
HK1206741A1 (en) Novel phenyl-pyridine/pyrazine amides for the treatment of cancer -/
EP2814479A4 (en) METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS
PL2855475T3 (pl) Alfa-karboliny do leczenia nowotworu
GB201217330D0 (en) Therapeutic for treating inflammatory lung disorders
IL234796B (en) Compounds for the treatment of diseases related to ischemia-reperfusion
PT2872131T (pt) Oleaceína para tratamento ou prevenção de doenças resultantes de placas ateroscleróticas
PT2692355T (pt) Apolactoferrina para o tratamento de doenças por acumulação de ferro
HK1210421A1 (en) Use of pregn-4-en-20-yn-3-one for the treatment of depressive disorders -4--20--3-
IL236873A0 (en) therapeutic compounds
PL399422A1 (pl) Sposób wytwarzania 2',4,4',6'-tetrahydroksydihydrochalkonu
PL399423A1 (pl) Sposób wytwarzania 2'-hydroksydihydrochalkonu
PL398695A1 (pl) Sposób wytwarzania 2'-hydroksydihydrochalkonu
GB201205449D0 (en) Treatment process
AP2015008270A0 (en) Preparation for the treatment of tuberculosis